Evaluation of Performance of the BD Veritor SARS-CoV-2 Chromatographic Immunoassay Test in Patients with Symptoms of COVID-19

J Clin Microbiol. 2021 Apr 20;59(5):e00260-21. doi: 10.1128/JCM.00260-21. Print 2021 Apr 20.

Authors

Abdullah Kilic¹, Brian Hiestand², Elizabeth Palavecino³

Affiliations

¹ Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA akilic@wakehealth.edu.
² Department of Emergency Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
³ Department of Pathology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

No abstract available

Keywords: COVID-19; Simplexa RT-PCR; antigen test; the Veritor test.

Publication types

Letter
Comment

MeSH terms

COVID-19*
Clinical Laboratory Techniques
Humans
Immunoassay
Point-of-Care Testing
Polymerase Chain Reaction
SARS-CoV-2*